Whitehawk Therapeutics (WHWK) Operating Income (2018 - 2025)
Historic Operating Income for Whitehawk Therapeutics (WHWK) over the last 8 years, with Q3 2025 value amounting to -$19.5 million.
- Whitehawk Therapeutics' Operating Income fell 4572.43% to -$19.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$108.5 million, marking a year-over-year decrease of 6378.3%. This contributed to the annual value of -$67.5 million for FY2024, which is 622.11% up from last year.
- Whitehawk Therapeutics' Operating Income amounted to -$19.5 million in Q3 2025, which was down 4572.43% from -$54.7 million recorded in Q2 2025.
- In the past 5 years, Whitehawk Therapeutics' Operating Income registered a high of -$3.9 million during Q2 2021, and its lowest value of -$87.3 million during Q3 2021.
- In the last 5 years, Whitehawk Therapeutics' Operating Income had a median value of -$16.8 million in 2023 and averaged -$21.2 million.
- As far as peak fluctuations go, Whitehawk Therapeutics' Operating Income crashed by 317867.07% in 2021, and later skyrocketed by 8277.88% in 2022.
- Over the past 5 years, Whitehawk Therapeutics' Operating Income (Quarter) stood at -$15.9 million in 2021, then increased by 2.97% to -$15.5 million in 2022, then fell by 14.49% to -$17.7 million in 2023, then dropped by 6.97% to -$18.9 million in 2024, then dropped by 3.15% to -$19.5 million in 2025.
- Its last three reported values are -$19.5 million in Q3 2025, -$54.7 million for Q2 2025, and -$15.2 million during Q1 2025.